Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bi-Weekly Docetaxel in Elderly NSCLC
NCT00227708Phase 2Completed
- Sponsor
- Unicancer
- Start
- Jun 2005
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of docetaxel in non-small cell lung cancer (NSCLC), sponsored by Unicancer. Started Jun 2005; status: completed.
02
Drugs
docetaxel
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00227708.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00227708.